Bionano Genomics (BNGO) Other Non-Current Assets (2020 - 2026)

Bionano Genomics (BNGO) has 7 years of Other Non-Current Assets data on file, last reported at $2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets changed N/A year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (changed N/A YoY), and the FY2025 full-year result was $2.7 million, up 573.5% from the prior year.
• Other Non-Current Assets retreated to $2.7 million in Q1 2026, from $2.7 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $11.4 million in Q2 2024 to a low of $400000.0 in Q4 2022.
• A 5-year average of $2.4 million and a median of $400000.0 in 2022 frame the typical range for Other Non-Current Assets.
• Peak annual rise in Other Non-Current Assets reached 2752.0% in 2024, while the deepest fall reached 94.62% in 2024.
• Tracing BNGO's Other Non-Current Assets over 5 years: stood at $400000.0 in 2022, then soared by 1757.75% to $7.4 million in 2023, then plunged by 94.62% to $400000.0 in 2024, then soared by 573.5% to $2.7 million in 2025, then fell by 0.59% to $2.7 million in 2026.
• Business Quant data shows BNGO's Other Non-Current Assets at $2.7 million in Q1 2026, $2.7 million in Q4 2025, and $2.1 million in Q2 2025.